APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dengue Vaccines

Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.

Selected research

Market Structure

Global Dengue Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025175 pages

Choose your research edition.

Industry ResearchDengue Vaccines Industry Research Report 2026102 pages · $2,950 USDIndustry Growth & TrendsGlobal Dengue Vaccines Industry Growth and Trends Forecast to 203260 pages · $3,450 USDMarket StructureGlobal Dengue Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dengue Vaccines Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Dengue Vaccines Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.

The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.

Report Includes

Read the full market overview

This report provides an overview of the global Dengue Vaccines market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dengue Vaccines and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dengue Vaccines revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Dengue Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Dengue Vaccines Segment by Company

Sanofi

Takeda

Dengue Vaccines Segment by Type

Dengvaxia

TAK-003

Others

Dengue Vaccines Segment by Application

Public Sector

Private Sector

Dengue Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dengue Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dengue Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dengue Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Dengue Vaccines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dengue Vaccines industry.

Chapter 3: Detailed analysis of Dengue Vaccines companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dengue Vaccinesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dengue Vaccines Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Dengvaxia Table 3. Key Players of TAK-003 Table 4. Key Players of Others Table 4. Global Dengue Vaccines Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Public Sector Table 6. Key Players of Private Sector Table 7. Global Dengue Vaccines Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Dengue Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Dengue Vaccines Market Share by Region (2021-2026) Table 10. Global Dengue Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Dengue Vaccines Market Share by Region (2027-2032) Table 12. Dengue Vaccines Industry Trends Table 13. Dengue Vaccines Industry Drivers Table 14. Dengue Vaccines Industry Opportunities and Challenges Table 15. Dengue Vaccines Industry Restraints Table 16. Global Dengue Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Dengue Vaccines Revenue Market Share by Company (2021-2026) Table 18. Global Dengue Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Dengue Vaccines Key Company Head Office and Area Served Table 20. Global Dengue Vaccines Company, Product Type & Application Table 21. Global Dengue Vaccines Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Dengue Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Dengue Vaccines Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dengue Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Dengue Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Dengue Vaccines Revenue Market Share by Type (2021-2026) Table 28. Global Dengue Vaccines Revenue Market Share by Type (2027-2032) Table 29. Global Dengue Vaccines Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Dengue Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Dengue Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Dengue Vaccines Revenue Market Share by Application (2021-2026) Table 33. Global Dengue Vaccines Revenue Market Share by Application (2027-2032) Table 34. Sanofi Company Information Table 35. Sanofi Business Overview Table 36. Sanofi Dengue Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Sanofi Dengue Vaccines Product Portfolio Table 38. Sanofi Recent Development Table 39. Takeda Company Information Table 40. Takeda Business Overview Table 41. Takeda Dengue Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Takeda Dengue Vaccines Product Portfolio Table 43. Takeda Recent Development Table 44. North America Dengue Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 45. North America Dengue Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 46. North America Dengue Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 47. North America Dengue Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 48. North America Dengue Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 49. North America Dengue Vaccines Market Size by Country (2021-2026) Table 50. North America Dengue Vaccines Market Size by Country (2027-2032) Table 51. Europe Dengue Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 52. Europe Dengue Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 53. Europe Dengue Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 54. Europe Dengue Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 55. Europe Dengue Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Europe Dengue Vaccines Market Size by Country (2021-2026) Table 57. Europe Dengue Vaccines Market Size by Country (2027-2032) Table 58. China Dengue Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 59. China Dengue Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 60. China Dengue Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 61. China Dengue Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 62. Asia Dengue Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 63. Asia Dengue Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 64. Asia Dengue Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 65. Asia Dengue Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 66. Asia Dengue Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 67. Asia Dengue Vaccines Market Size by Country (2021-2026) Table 68. Asia Dengue Vaccines Market Size by Country (2027-2032) Table 69. South America, Middle East & Africa Dengue Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 70. South America, Middle East & Africa Dengue Vaccines Market Size by Type (2027-2032) & (US$ Million) Table 71. South America, Middle East & Africa Dengue Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 72. South America, Middle East & Africa Dengue Vaccines Market Size by Application (2027-2032) & (US$ Million) Table 73. South America, Middle East & Africa Dengue Vaccines Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. South America, Middle East & Africa Dengue Vaccines Market Size by Country (2021-2026) Table 75. South America, Middle East & Africa Dengue Vaccines Market Size by Country (2027-2032) Table 76. Research Programs/Design for This Report Table 77. Authors List of This Report Table 78. Secondary Sources Table 79. Primary Sources List of Figures Figure 1. Dengue Vaccines Product Image Figure 2. Global Dengue Vaccines Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Dengue Vaccines Market Share by Type: 2025 VS 2032 Figure 4. Dengvaxia Image Figure 5. TAK-003 Image Figure 6. Others Image Figure 7. Global Dengue Vaccines Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Dengue Vaccines Market Share by Application: 2025 VS 2032 Figure 9. Public Sector Image Figure 10. Private Sector Image Figure 11. Global Dengue Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 13. Global Dengue Vaccines Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Dengue Vaccines Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Dengue Vaccines Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Dengue Vaccines Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Dengue Vaccines Revenue Market Share by Type (2021-2032) Figure 20. Global Dengue Vaccines Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Dengue Vaccines Revenue Market Share by Application (2021-2032) Figure 22. North America Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 23. North America Dengue Vaccines Market Share by Type (2021-2032) Figure 24. North America Dengue Vaccines Market Share by Application (2021-2032) Figure 25. North America Dengue Vaccines Market Share by Country (2021-2032) Figure 26. United States Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 27. Canada Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 29. Europe Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 30. Europe Dengue Vaccines Market Share by Type (2021-2032) Figure 31. Europe Dengue Vaccines Market Share by Application (2021-2032) Figure 32. Europe Dengue Vaccines Market Share by Country (2021-2032) Figure 33. Germany Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 34. France Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 36. Italy Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 37. Russia Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 39. China Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 40. China Dengue Vaccines Market Share by Type (2021-2032) Figure 41. China Dengue Vaccines Market Share by Application (2021-2032) Figure 42. Asia Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 43. Asia Dengue Vaccines Market Share by Type (2021-2032) Figure 44. Asia Dengue Vaccines Market Share by Application (2021-2032) Figure 45. Asia Dengue Vaccines Market Share by Country (2021-2032) Figure 46. Japan Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 50. India Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 51. Australia Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Dengue Vaccines Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Dengue Vaccines Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Dengue Vaccines Market Share by Country (2021-2032) Figure 56. Brazil Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 61. UAE Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 63. Chile Dengue Vaccines Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Dengvaxia
  • TAK-003
  • Others
Applications
  • Public Sector
  • Private Sector
Companies covered
  • Sanofi
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Dengue Vaccines Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Dengvaxia
  5. 1.2.3 TAK-003
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Dengue Vaccines Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Public Sector
  10. 1.3.3 Private Sector
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Dengue Vaccines Growth Trends by Region
  13. 1.5.1 Global Dengue Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Dengue Vaccines Market Size by Region (2021-2026)
  15. 1.5.3 Dengue Vaccines Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Dengue Vaccines Market Dynamics
  1. 2.1 Dengue Vaccines Industry Trends
  2. 2.2 Dengue Vaccines Industry Drivers
  3. 2.3 Dengue Vaccines Industry Opportunities and Challenges
  4. 2.4 Dengue Vaccines Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Dengue Vaccines Revenue by Company (2021-2026)
  2. 3.2 Global Dengue Vaccines Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Dengue Vaccines Key Company Head office and Area Served
  4. 3.4 Global Dengue Vaccines Company, Product Type & Application
  5. 3.5 Global Dengue Vaccines Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Dengue Vaccines Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Dengue Vaccines Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Dengue Vaccines Tier 1, Tier 2, and Tier 3
4 Dengue Vaccines Market by Type
  1. 4.1 Global Dengue Vaccines Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Dengue Vaccines Market Size by Type (2021-2032)
  3. 4.3 Global Dengue Vaccines Market Size Share by Type (2021-2032)
5 Dengue Vaccines Market by Application
  1. 5.1 Global Dengue Vaccines Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Dengue Vaccines Market Size by Application (2021-2032)
  3. 5.3 Global Dengue Vaccines Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Dengue Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Sanofi Dengue Vaccines Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Dengue Vaccines Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Takeda Dengue Vaccines Product Portfolio
  12. 6.2.5 Takeda Recent Developments
7 North America
  1. 7.1 North America Dengue Vaccines Market Size (2021-2032)
  2. 7.2 North America Dengue Vaccines Market Size by Type
  3. 7.2.1 North America Dengue Vaccines Market Size by Type (2021-2026)
  4. 7.2.2 North America Dengue Vaccines Market Size by Type (2027-2032)
  5. 7.2.3 North America Dengue Vaccines Market Share by Type (2021-2032)
  6. 7.3 North America Dengue Vaccines Market Size by Application
  7. 7.3.1 North America Dengue Vaccines Market Size by Application (2021-2026)
  8. 7.3.2 North America Dengue Vaccines Market Size by Application (2027-2032)
  9. 7.3.3 North America Dengue Vaccines Market Share by Application (2021-2032)
  10. 7.4 North America Dengue Vaccines Market Size by Country
  11. 7.4.1 North America Dengue Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Dengue Vaccines Market Size by Country (2021-2026)
  13. 7.4.3 North America Dengue Vaccines Market Size by Country (2027-2032)
  14. 7.4.4 North America Dengue Vaccines Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Dengue Vaccines Market Size (2021-2032)
  2. 8.2 Europe Dengue Vaccines Market Size by Type
  3. 8.2.1 Europe Dengue Vaccines Market Size by Type (2021-2026)
  4. 8.2.2 Europe Dengue Vaccines Market Size by Type (2027-2032)
  5. 8.2.3 Europe Dengue Vaccines Market Share by Type (2021-2032)
  6. 8.3 Europe Dengue Vaccines Market Size by Application
  7. 8.3.1 Europe Dengue Vaccines Market Size by Application (2021-2026)
  8. 8.3.2 Europe Dengue Vaccines Market Size by Application (2027-2032)
  9. 8.3.3 Europe Dengue Vaccines Market Share by Application (2021-2032)
  10. 8.4 Europe Dengue Vaccines Market Size by Country
  11. 8.4.1 Europe Dengue Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Dengue Vaccines Market Size by Country (2021-2026)
  13. 8.4.3 Europe Dengue Vaccines Market Size by Country (2027-2032)
  14. 8.4.4 Europe Dengue Vaccines Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Dengue Vaccines Market Size (2021-2032)
  2. 9.2 China Dengue Vaccines Market Size by Type
  3. 9.2.1 China Dengue Vaccines Market Size by Type (2021-2026)
  4. 9.2.2 China Dengue Vaccines Market Size by Type (2027-2032)
  5. 9.2.3 China Dengue Vaccines Market Share by Type (2021-2032)
  6. 9.3 China Dengue Vaccines Market Size by Application
  7. 9.3.1 China Dengue Vaccines Market Size by Application (2021-2026)
  8. 9.3.2 China Dengue Vaccines Market Size by Application (2027-2032)
  9. 9.3.3 China Dengue Vaccines Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Dengue Vaccines Market Size (2021-2032)
  2. 10.2 Asia Dengue Vaccines Market Size by Type
  3. 10.2.1 Asia Dengue Vaccines Market Size by Type (2021-2026)
  4. 10.2.2 Asia Dengue Vaccines Market Size by Type (2027-2032)
  5. 10.2.3 Asia Dengue Vaccines Market Share by Type (2021-2032)
  6. 10.3 Asia Dengue Vaccines Market Size by Application
  7. 10.3.1 Asia Dengue Vaccines Market Size by Application (2021-2026)
  8. 10.3.2 Asia Dengue Vaccines Market Size by Application (2027-2032)
  9. 10.3.3 Asia Dengue Vaccines Market Share by Application (2021-2032)
  10. 10.4 Asia Dengue Vaccines Market Size by Country
  11. 10.4.1 Asia Dengue Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Dengue Vaccines Market Size by Country (2021-2026)
  13. 10.4.3 Asia Dengue Vaccines Market Size by Country (2027-2032)
  14. 10.4.4 Asia Dengue Vaccines Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Dengue Vaccines Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Dengue Vaccines Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Dengue Vaccines Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Dengue Vaccines Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Dengue Vaccines Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Dengue Vaccines Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Dengue Vaccines Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Dengue Vaccines Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Dengue Vaccines Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Dengue Vaccines Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Dengue Vaccines Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Dengue Vaccines Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Dengue Vaccines Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Dengue Vaccines Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst